Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

BOM:524412 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,931	942	1,253	601	1,051	543
Market Cap Growth	19.41%	-24.82%	108.61%	-42.83%	93.71%	74.44%
Enterprise Value	2,418	1,314	1,553	842	1,276	716
Last Close Price	68.82	33.71	44.68	23.67	41.40	23.20
PE Ratio	54.87	23.42	26.76	15.93	16.03	8.33
PS Ratio	0.45	0.20	0.31	0.14	0.21	0.15
PB Ratio	1.30	0.68	0.94	0.51	0.93	0.55
P/TBV Ratio	1.30	0.68	0.94	0.51	0.93	0.55
P/FCF Ratio	63.07	18.49	-	-	-	20.89
P/OCF Ratio	11.14	9.15	-	-	210.69	9.91
EV/Sales Ratio	0.56	0.28	0.39	0.20	0.26	0.20
EV/EBITDA Ratio	37.20	18.61	13.54	10.18	10.62	7.83
EV/EBIT Ratio	55.82	25.69	15.89	12.58	12.73	8.70
EV/FCF Ratio	79.00	25.78	-	-	-	27.58
Debt / Equity Ratio	0.38	0.31	0.24	0.32	0.13	0.18
Debt / EBITDA Ratio	8.76	6.17	2.73	4.56	1.18	1.97
Debt / FCF Ratio	18.61	8.55	-	-	-	6.94
Asset Turnover	1.51	1.60	1.35	1.56	2.06	1.65
Inventory Turnover	12.12	6.43	5.57	6.66	9.16	5.49
Quick Ratio	0.91	0.92	1.13	1.14	1.08	1.24
Current Ratio	1.80	1.78	1.70	1.61	1.73	1.67
Return on Equity (ROE)	2.52%	2.97%	3.74%	3.26%	6.17%	6.81%
Return on Assets (ROA)	0.95%	1.08%	2.05%	1.56%	2.62%	2.41%
Return on Invested Capital (ROIC)	1.43%	1.85%	3.82%	2.96%	5.12%	4.53%
Return on Capital Employed (ROCE)	2.90%	3.60%	7.10%	5.40%	8.50%	8.10%
Earnings Yield	1.86%	4.27%	3.74%	6.28%	6.24%	12.01%
FCF Yield	1.59%	5.41%	-2.96%	-3.87%	-1.62%	4.79%
Buyback Yield / Dilution	-6.38%	-11.18%	0.26%	-5.84%	-2.95%	-
Total Shareholder Return	-6.38%	-11.18%	0.26%	-5.84%	-2.95%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.